bluebird bio, Inc. (BLUE) financial statements (2021 and earlier)

Company profile

Business Address 60 BINNEY STREET
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,1571,2341,5599191,1061,1921,270
Cash and cash equivalents3183241,199347327300281
Short-term investments839910360572779892989
Restricted cash and investments2    00
Prepaid expense37353940332725
Other undisclosed current assets20241581315
Total current assets:1,2161,2931,6139671,1521,2201,301
Noncurrent Assets
Operating lease, right-of-use asset184188189194186192 
Property, plant and equipment163158155154151144129
Long-term investments and receivables12320849108132226288
Long-term investments12320849108132226288
Intangible assets, net (including goodwill)23242526272930
Goodwill13131313131313
Intangible assets, net (excluding goodwill)10111213141516
Restricted cash and investments      54
Other noncurrent assets73747579798285
Other undisclosed noncurrent assets      136
Total noncurrent assets:566652494562575672723
TOTAL ASSETS:1,7811,9452,1081,5291,7271,8922,023
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1009998801154229
Accounts payable22252631434229
Accrued liabilities2224332627  
Employee-related liabilities5649392445  
Deferred revenue214688 
Debt   202020 
Contract with customer, liability9
Other liabilities     11291
Other undisclosed current liabilities102979678801332
Total current liabilities:204197197184224196162
Noncurrent Liabilities
Long-term debt and lease obligation168173175180171176 
Operating lease, liability168173175180171176 
Liabilities, other than long-term debt33313017202221
Deferred revenue262626101012 
Contract with customer, liability14
Other liabilities7543242
Business combination, contingent consideration, liability   5876
Other undisclosed noncurrent liabilities222224272826204
Total noncurrent liabilities:223226229224219224225
Total liabilities:426422426409442421387
Stockholders' equity
Stockholders' equity attributable to parent1,3551,5231,6821,1201,2851,4721,636
Common stock1111111
Additional paid in capital4,2604,2274,1903,6073,5683,5333,489
Accumulated other comprehensive loss(6)(4)(2)(3)(2)(3)(1)
Accumulated deficit(2,901)(2,701)(2,506)(2,484)(2,282)(2,059)(1,852)
Total stockholders' equity:1,3551,5231,6821,1201,2851,4721,636
TOTAL LIABILITIES AND EQUITY:1,7811,9452,1081,5291,7271,8922,023

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues11191992210913
Cost of revenue(1)(1)(2) (3)(2)(1)
Cost of goods and services sold(1)(1)(2) (1)(1)(1)
Gross profit:918197227712
Operating expenses(214)(208)(225)(227)(238)(218)(215)
Other undisclosed operating income1122   
Operating loss:(204)(190)(26)(203)(231)(210)(203)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
3(7)2(4)1(4)(3)
Loss from continuing operations before equity method investments, income taxes:(201)(196)(24)(208)(230)(215)(206)
Other undisclosed income from continuing operations before income taxes1235789
Loss from continuing operations before income taxes:(200)(194)(21)(203)(223)(206)(196)
Income tax expense (benefit)(0)(0)(0)(0)(0)00
Net loss available to common stockholders, diluted:(200)(195)(21)(203)(223)(206)(196)

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net loss:(200)(195)(21)(203)(223)(206)(196)
Other comprehensive income (loss) (0)(0)(1)1(2)1
Other undisclosed comprehensive loss(4)      
Comprehensive loss:(203)(195)(22)(204)(222)(208)(195)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent2(2)0    
Comprehensive loss, net of tax, attributable to parent:(201)(197)(21)(204)(222)(208)(195)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: